ZeptoMetrix NATtrol SARS-CoV-2 Recombinant Construct

Mar 11, 2020

ZeptoMetrix has released its newly inactivated and non-infectious NATtrol SARS-CoV-2 Recombinant construct for laboratory quality control and test validation.

This non-infectious quality control incorporates a recombinant construct associated with targeted detection regions of the virus that may be used in the development of molecular assays designed to detect SARS-CoV-2. It can also be used in BSL-2 facilities in place of the live virus, as non-infectious, external quality controls for assays developed to detect SARS-CoV-2, the company said.

ZeptoMetrix NATtrol SARS-CoV-2 Recombinant Construct

Grail Q1 Revenues up 19 Percent Driven by Clinical Test Growth

Seer Q1 Revenues Rise 35 Percent

Biodesix Q1 Revenues up 21 Percent as Firm Slashes Full-Year Guidance on Sales Restructuring

MantaBio Nabs $2.5M in Seed Funding to Develop Microbial Detection Platform for Biopharma

Socioeconomic Factors, Not Genetic Ancestry, Linked to All-Cause Mortality in Black Americans